Milestone Pharmaceuticals Inc.
Price Action
Technical Summary
CONSOLIDATINGMilestone Pharmaceuticals Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is moderate (RS Rating: 56), indicating performance broadly in line with the market. Earnings growth of 25% provides fundamental context to the price action. Investors should exercise caution due to high volatility (85% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $1.95 | +0.79% | ABOVE |
| 50 SMA | $1.70 | +15.95% | ABOVE |
| 100 SMA | $1.84 | +7.08% | ABOVE |
| 150 SMA | $1.94 | +1.43% | ABOVE |
| 200 SMA | $1.89 | +4.25% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is MIST in an uptrend right now?
MIST has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is MIST overbought or oversold?
MIST's RSI (14) is 54. The stock is in neutral territory, neither overbought nor oversold.
Is MIST outperforming the market?
MIST has a Relative Strength (RS) Rating of 56 out of 99. MIST is performing about average compared to the market.
Where is MIST in its 52-week range?
MIST is trading at $1.97, which is 64% of its 52-week high ($3.06) and 47% above its 52-week low ($1.00).
How volatile is MIST?
MIST has a Beta of 2.11 and 52-week volatility of 85%. It's more volatile than the S&P 500 - expect bigger swings.